Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II randomized open-label study of intra-articular TNP-2092 for prosthetic joint infection after total knee arthroplasty
CTR20250773Phase 2Active
- Sponsor
- TenNor Therapeutics
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rifaquizinone in periprosthetic joint infection (PJI), sponsored by TenNor Therapeutics. Started Apr 2025; status: active.
02
Drugs
rifaquizinone
03
Conditions
periprosthetic joint infection (PJI)
Beyond the preview
Go deeper on CTR20250773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250773.